stonks4u
Sign up free
ZEAL logo

ZEAL Zealand Pharma A/S

NASDAQ Global Select · Biotechnology · Healthcare

$17.59
+0.00 (+0.00%)

Founded in 1998 and headquartered in Copenhagen, Denmark, Zealand Pharma A/S is a biotechnology firm focused on the discovery, development, and commercialization of peptide-based medications. The company's therapeutic pipeline and marketed products primarily address gastrointestinal and metabolic diseases, as well as other niche conditions with significant unmet medical needs. Currently, Zealand P…

Market Cap: $0.00www.zealandpharma.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

80
8093107120
Aug 10Aug 13

Quote

Day Range
$17.47 – $18.07
52-Week Range
$9.93 – $32.12
Volume
$2.2K
Market Cap
$0.00
50-Day Avg
$17.78
200-Day Avg
$15.58
Prev Close
$17.59
Open
$18.03

Valuation & Ratios

P/E Ratio
-5.26
EPS
$-26.54
P/B Ratio
5.77
P/S Ratio
18.30
Debt/Equity
0.85
Current Ratio
5.15
Dividend Yield
+0.0%
Gross Margin
+59.4%

Returns & Efficiency

Return on Equity
-109.7%
Return on Assets
-49.2%
FCF Yield
-23.1%
EV/EBITDA
-5.10

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2021$292.57M$-1.02B$-26.54
2020$353.31M$-846.73M$-22.07
2019$41.33M$-571.54M$-16.91
2018$37.98M$581.28M$18.94
2017$139.78M$-272.27M$-9.77

Social Signal Score

46
5d
30
1 mentions
—
30d
51
2 mentions
—
60d
51
2 mentions
—
90d
51
2 mentions
—
news: 2

Earnings

5of 8 quarters beat consensus

Typical surprise +14.1% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 11$-11.04 vs $-5.84miss
  • Thu, May 12$-5.16 vs $-6.61beat
  • Thu, Nov 11$-4.61 vs $-6.31beat
  • Thu, Aug 12$-1.11 vs $-5.77beat
  • Wed, May 12$-5.78 vs $-6.17beat
  • Thu, Mar 11$-9.76 vs $-5.90miss

Estimates and results for ZEAL via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

ZEALhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (2)

  • Newsglobenewswire.com·2d ago·Negative

    Zealand Pharma Announces Financial Results for the First Half of 2026 Company announcement – No. 39 / 2026 Zealand Pharma Announces Financial Results for the First Half of 2026 A landmark first half defined by key milestones delivered for leading obesity assets, and a continued momentum building across all fronts of our Metabolic Frontier 2030 strategy.

    View source ↗
  • Newsglobenewswire.com·5d ago·Positive

    Zealand Pharma - Transactions related to share buy-back program (week 32, 2026) Company announcement No. 37 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 32, 2026) Copenhagen, Denmark, August 10, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no.

    View source ↗